Explore All 3113 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | November 17, 2025 |
| Target | Halda Therapeutics |
| Sector | Life Science |
| Buyer(s) | Johnson & Johnson |
| Deal Type | Add-on Acquisition |
| Deal Value | 3.1B USD |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1886 |
| Sector | Consumer Products |
| Employees | 132,000 |
| Revenue | 88.8B USD (2024) |
Johnson & Johnson is a global healthcare conglomerate that operates across three primary sectors: Pharmaceuticals, Medical Devices, and Consumer Health. In Pharmaceuticals, it develops treatments for a variety of conditions, including immunology, oncology, and infectious diseases. The Medical Devices segment offers a range of equipment and devices for healthcare professionals, encompassing orthopedics, surgery, and cardiovascular care. Its Consumer Health division markets a wide array of products, spanning baby care, oral care, skin care, over-the-counter drugs, and women's health, with popular brands such as Band-Aid, Tylenol, and Neutrogena under its umbrella. Johnson & Johnson was formed in 1886 and is based in New Brunswick, New Jersey.
| Deal Context for Buyer | # |
|---|---|
| Overall | 47 of 47 |
| Sector: Life Science | 20 of 20 |
| Type: Add-on Acquisition | 39 of 39 |
| State: Connecticut | 1 of 1 |
| Country: United States | 39 of 39 |
| Year: 2025 | 2 of 2 |
| Size (of disclosed) | 11 of 31 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-01-13 |
Intra-Cellular Therapies
Bedminster, New Jersey, United States Intra-Cellular Therapies is a biopharmaceutical company. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. Intra-Cellular Therapies was founded in 2002 and is based in Bedminster, New Jersey. |
Buy | $14.6B |
